Results 271 to 280 of about 67,076 (344)

Surgery for metabolic liver disease [PDF]

, 1986
Starzl, TE
core  

Mitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches

MedComm – Future Medicine, Volume 4, Issue 3, September 2025.
Mitochondria play a critical role in aging and aging‐related diseases. This review systematically explores the mechanisms underlying mitochondrial deterioration during aging and highlights innovative therapeutic strategies for these mitochondrial problems.
Lanlan Jia, Ziyu Wei, Jinyuan Luoqian, Xi Wang, Chao Huang   +4 more
wiley   +1 more source

Empagliflozin as treatment in glycogen storage disease type IB patients. [PDF]

Mol Genet Metab Rep
Arbelo Rodríguez M, Márquez Mesa E, Lorenzo González C, Gutiérrez Vilar M, Arhip L, Ruiz Pons M, Suárez Llanos JP.   +6 more
europepmc   +1 more source

Chronic idiopathic myopathy in Icelandic horses: A case series

Equine Veterinary Journal, Volume 57, Issue 5, Page 1341-1346, September 2025.
Abstract Background Exertional myopathies are recognised as a cause of poor performance in equines. In Icelandic horses presenting reduced performance and/or multi‐limb lameness, no specific myopathy has been identified. Objectives To characterise the clinical presentation and histopathological findings in muscle biopsy samples from Icelandic horses ...
Sanni Hansen, Charlotte Hopster‐Iversen, Lise Berg, Julie Fjeldborg, Claire Massey, Richard J. Piercy, Helena Carstensen   +6 more
wiley   +1 more source

GLP-1 and Its Role in Glycogen Production: A Narrative Review. [PDF]

Biomedicines
Lotosky J, Jean X, Altankhuyag A, Khan S, Bernotas A, Sharafshah A, Blum K, Posner A, Thanos PK.   +8 more
europepmc   +1 more source

Opposite kinetics of L-leucine and L-phenylalanine induced insulin release studies with the perfused rat pancreas [PDF]

, 1972
Landgraf, R., Landgraf-Leurs, M. M. C., Schwarz, K., Scriba, Peter Christian   +3 more
core  

People and Families Affected by Glycogen Storage Disease Type Ia: An Analysis of Narrative Accounts Written by Individuals Living with GSDIa and Their Caregivers. [PDF]

J Health Econ Outcomes Res
Kruger E, de Freitas HM, Ferrecchia I, Gaydon M, Lloyd A.   +4 more
europepmc   +1 more source

Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa. [PDF]

Cureus
Miyaishi M, Fukushima K, Kuranobu N, Murakami J, Namba N.   +4 more
europepmc   +1 more source

Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia. [PDF]

Sci Rep
Pirozzi F, Amiri R, Luni C, Rossi A, Melis D, Fedele R, Rosano C, Strisciuglio P, Oosterveer MH, Derks TGJ, Parenti G, Caterino M, Ruoppolo M.   +12 more
europepmc   +1 more source

Galectin-3: a novel biomarker of glycogen storage disease type III. [PDF]

Cell Death Discov
Rossiaud L, Miagoux Q, Benabides M, Reiss O, Jauze L, Jarrige M, Polvèche H, Malfatti E, Laforêt P, Ronzitti G, Nissan X, Hoch L.   +11 more
europepmc   +1 more source